Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Preclinical efficacy and safety of AAVrh10-based plakophilin-2 gene therapy (LX2020) as a treatment for arrhythmogenic cardiomyopathy.
Journal: NPJ Regenerative medicine
Published: November 05, 2024
Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics.
Journal: Nature cardiovascular research
Published: March 23, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026